Cefuroxime Injection, Powder, For Solution
Product Images NDC 0143-9976
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cefuroxime (NDC 0143-9976). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Cefuroxime For Injection Pbp 2
This is a description of Cefuroxime for Injection, which comes in a Pharmacy bulk package of 7.5g per vial and is not meant for direct infusion. The package is not to be dispensed as a unit, and its use is reserved for intravenous use only. The package has instructions for constitution and further dilution before use but is not intended for immediate administration. The package is meant for pharmacy bulk use and has 53 pharmacy doses per unit. The package comes with a warning to protect the contents from temperature changes and to discard unused portions. The package is made by Higha Farmaceutica, with a lot number available.*
Cefuroxime For Injection Pbp 3
Cefuroxime for injection, USP is a pharmacy bulk package that is not for direct infusion. The package has a 5g and a 7.5g per vial concentration, with 10x7.5g Vials. The package is Rx only and is for intravenous use only. The package has a NDC code of 0143-997-6-03. The instructions on how to open the package are not legible. The package has to be discarded 4 hours after initial battery, and the contents should be withdrawn without delay. The dosage, storage details and manufacturer's information are also present.*
Cefuroxime For Injection Pbp 4
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.